Teva Pharmaceutical Industries Ltd. (TEVA) - Financials, balance sheet (annual)

6,053 ILA

104

1.75%

Last update May 25, 3:49 PM IDT

Market closed

Day range

6,053

6,036

6,097

Previous close

5,949

Open

6,038

Access this stock data via API

Teva Pharmaceutical Industries Ltd.

6,053.00

104

1.75%

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	39.3B	43.5B	44.0B	47.7B
Current assets	12.6B	12.5B	12.1B	12.6B
Cash	1.3B	1.5B	1.6B	1.9B
Cash equivalents	2.0B	1.7B	1.2B	220M
Cash and cash equivalents	3.3B	3.2B	2.8B	2.2B
Other short term investments	—	—	—	—
Accounts receivable	3.1B	3.4B	3.7B	4.5B
Other receivables	—	—	—	—
Inventory	3.0B	4.0B	3.8B	3.8B
Prepaid assets	1.0B	1.3B	1.2B	1.1B
Restricted cash	—	—	—	—
Assets held for sale	1.8B	70M	10M	19M
Hedging assets	—	—	—	—
Other current assets	409M	505M	549M	967M
Non current assets	26.8B	31.0B	32.0B	35.1B
Properties	367M	397M	419M	495M
Land and improvements	213M	246M	246M	262M
Machinery furniture equipment	5.5B	7.2B	7.3B	7.4B
Construction in progress	1.3B	1.4B	1.2B	1.0B
Leases	—	—	—	—
Accumulated depreciation	-4.4B	-5.6B	-5.5B	-5.2B
Goodwill	34.7B	39.7B	41.5B	47.5B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	4.4B	5.4B	6.3B	7.5B
Investments and advances	—	—	—	—
Other non current assets	2.3B	2.3B	1.9B	1.1B
Total liabilities	33.6B	35.4B	35.4B	36.4B
Current liabilities	12.8B	12.2B	11.5B	11.0B
Accounts payable	2.2B	2.6B	1.9B	1.7B
Accrued expenses	2.8B	2.8B	2.2B	2.2B
Short term debt	1.8B	1.7B	2.1B	1.4B
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	624M	611M	566M	563M
Other current liabilities	1.7B	1.1B	1.0B	903M
Non current liabilities	20.8B	23.1B	23.9B	25.4B
Long term provisions	—	—	—	—
Long term debt	16.3B	18.5B	19.5B	22.0B
Provision for risks and charges	—	—	3.8B	2.6B
Deferred liabilities	483M	606M	548M	784M
Derivative product liabilities	—	—	—	—
Other non current liabilities	4.0B	4.0B	3.9B	—
Shareholders equity
Common stock	58M	57M	57M	57M
Retained earnings	-15.2B	-13.5B	-13.0B	-10.5B
Other shareholders equity	-3.1B	-2.7B	-2.8B	-2.7B
Total shareholders equity	5.7B	8.1B	8.6B	11.2B
Additional paid in capital	27.8B	27.8B	27.7B	27.6B
Treasury stock	4.1B	4.1B	4.1B	4.1B
Minority interest	347M	620M	794M	966M